Estrella Immunopharma Inc. • ESLA

Capital at risk.

About Estrella Immunopharma Inc.
Ticker
info
ESLA
Trading on
info
NASDAQ
ISIN
info
US2975841048
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Cheng Liu Ph.D.
Headquarters
info
5858 Horton Street, EmeryVille, CA, United States, 94608
Employees
info
0
Website
info
estrellabio.com
Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It has a collaborative agreement with Eureka and Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California. Estrella Immunopharma, Inc. is a subsidiary of Eureka Therapeutics, Inc.
Metrics
BasicAdvanced
Market cap
info
$77.8M
P/E ratio
info
-
EPS
info
-$0.24
Dividend Yield
info
0.00%
Beta
info
0.52
Forward P/E ratio
info
0
EBIDTA
info
-
Ex dividend date
info
-
Price & volume
Market cap
info
$77.8M
Average daily volume
info
0.5M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
241.3
Earnings
EPS
info
-$0.24
EPS estimate (current quarter)
info
-$0.11
EPS estimate (next quarter)
info
$0.00
EBITDA
info
-
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
0.52
52-week High
info
$3.15
52-week Low
info
$0.73
50-day moving average
info
$1.65
200-day moving average
info
$1.15
Short ratio
info
0.17
Short %
info
0.57%
Management effectiveness
ROE (TTM)
info
-268.50%
ROA (TTM)
info
-100.93%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
37.1M
Float
info
11M
Insiders %
info
70.36%
Institutions %
info
2.08%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$16.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.09
-$0.12
25.00%
Q3 • 24Beat
-$0.03
-$0.12
75.00%
Q4 • 24Beat
-$0.06
-$0.11
45.45%
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-2.1M
-∞%
Q1 • 25
$0M
$-5.5M
-∞%
Q2 • 25
NaN%
163.50%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$2.4M
$4.3M
174.91%
Q1 • 25
$3M
$9.1M
304.48%
Q2 • 25
21.94%
112.27%
74.08%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-0.5M
-
$-0M
$-0.5M
Q1 • 25
$-0.4M
-
$1.3M
$-0.4M
Q2 • 25
-10.97%
-
-4,546.41%
-10.97%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Estrella Immunopharma Inc. share?
Collapse

Estrella Immunopharma Inc. shares are currently traded for undefined per share.

How many shares does Estrella Immunopharma Inc. have?
Collapse

Estrella Immunopharma Inc. currently has 37.1M shares.

Does Estrella Immunopharma Inc. pay dividends?
Collapse

No, Estrella Immunopharma Inc. doesn't pay dividends.

What is Estrella Immunopharma Inc. 52 week high?
Collapse

Estrella Immunopharma Inc. 52 week high is $3.15.

What is Estrella Immunopharma Inc. 52 week low?
Collapse

Estrella Immunopharma Inc. 52 week low is $0.73.

What is the 200-day moving average of Estrella Immunopharma Inc.?
Collapse

Estrella Immunopharma Inc. 200-day moving average is $1.15.

Who is Estrella Immunopharma Inc. CEO?
Collapse

The CEO of Estrella Immunopharma Inc. is Dr. Cheng Liu Ph.D..

How many employees Estrella Immunopharma Inc. has?
Collapse

Estrella Immunopharma Inc. has 0 employees.

What is the market cap of Estrella Immunopharma Inc.?
Collapse

The market cap of Estrella Immunopharma Inc. is $77.8M.

What is the P/E of Estrella Immunopharma Inc.?
Collapse

The current P/E of Estrella Immunopharma Inc. is null.

What is the EPS of Estrella Immunopharma Inc.?
Collapse

The EPS of Estrella Immunopharma Inc. is -$0.24.

What is the PEG Ratio of Estrella Immunopharma Inc.?
Collapse

The PEG Ratio of Estrella Immunopharma Inc. is null.

What do analysts say about Estrella Immunopharma Inc.?
Collapse

According to the analysts Estrella Immunopharma Inc. is considered a buy.